[1] 虞积耀,崔全才.消化系统肿瘤病理学和遗传学.人民卫生出版社,2006:194.6.
[2] Bruix J,Sherman M.Management of hepatocellular carcinoma:an update.Hepatology,2011,53:1020-1022.
[3] 程伟中,曾蒙苏.新型多功能磁共振对比剂Gd-EOB-DTPA在肝胆系统病变中的应用.临床放射学杂志,2005,24:1107-1110.
[4] Frericks BB,Loddenkemper C,Huppertz A,et al.Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.AJR,2009,193:1053-1060.
[5] Kim SH,Kim SH,Lee J,et al.Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma.AJR,2009,192:1675-1681.
[6] Sun HY,Lee JM,Shin CI,et al.Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas(<or=2 cm in diameter)from arterial enhancing pseudolesions.Invest Radiol,2010,45:96-103.
[7] Bashir MR,Gupta RT,Davenport MS,et al.Hepatocellular carcinoma in a North American population:Does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?J Magn Reson Imaging,2012,37:398-406.
[8] Park MJ,Kim YK,Lee MW,et al.Small hepatocellular carcinomas:improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.Radiology,2012,264:761-770.
[9] 梁波.普美显在肝局灶性结节增生与肝细胞癌鉴别诊断中的价值.医学影像学杂志,2015,25:2175-2179.
[10] International Working Party.Terminology of nodular hepatocellular lesions.Hepatology,1995,22:983-993.
[11] 郭天畅,伍彩云,温运雄,等.普美显磁共振增强成像在鉴别肝硬化结节与小肝癌的临床应用研究.中国CT和MRI杂志,2015,13:63-65.
[12] 丁莺,曾蒙苏.普美显在肝硬化结节多步癌变及肝细胞癌早期诊断中的应用.临床肝胆病杂志,2013,29:736-739. |
